Loading clinical trials...
Loading clinical trials...
Using Rapid Cycle Randomized Controlled Trials to Study a Tobacco Cessation Best Practice Advisory.
The existing tobacco cessation best practice advisory (BPA) fires for providers (physicians, residents, fellows, midwives, nurse practitioners, physician assistants) during outpatient encounters when a patient is identified as a current tobacco user in the Social History section of their chart. The BPA was designed to help facilitate tobacco cessation interventions; it is part of the The Centers for Medicare \& Medicaid Services (CMS) Quality Payment Program (QPP). The purpose of the project is to optimize this BPA utilization and improve patient outcomes by comparing multiple versions of the tobacco cessation BPA.
Age
12 - No limit years
Sex
ALL
Healthy Volunteers
No
New York University School of Medicine
New York, New York, United States
Start Date
October 3, 2018
Primary Completion Date
May 24, 2019
Completion Date
February 29, 2020
Last Updated
July 21, 2021
54,417
ACTUAL participants
Patient Outcomes
OTHER
Billing documentation
OTHER
Regulatory
OTHER
Lead Sponsor
NYU Langone Health
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06161675